ArticleScientific reports2026
Integrating CT radiomics and morphologic features for preoperative risk stratification of gastrointestinal stromal tumours.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To evaluate the feasibility of combining CT morphologic and radiomics features to predict malignancy risk in GIST patients and develop a multivariate regression model. Ninety-two patients with pathologically confirmed GISTs were enrolled. CT morphologic features were reviewed, and 42 radiomics features were extracted from the tumours on portal venous phase images. In the univariate analysis, each morphological and radiomics characteristic was compared between the low- and moderate/high-risk groups. Three multivariate regression models were performed for morphological, radiomics, and combined features to reveal the best predictor variables and model for malignancy risk prediction. In the multivariate regression model using CT morphologic features, the presence of tumour necrosis and tumour vessels were significant indicators for differentiating low-risk from moderate/high-risk GISTs (AUC = 0.81). In a model using CT radiomics features, skewness, total energy and GLCM_Idmn were significant indicators for differentiating both risk groups (AUC = 0.89). After combining both significant morphological and radiomic features in one model, the presence of tumour vessels and GLCM_Idmn were significant indicators for differentiating both risk groups (AUC = 0.90). Combined CT morphologic and radiomics analysis proved to be a useful method for differentiating low-risk from moderate/high-risk GISTs with high diagnostic performance. This integration has the power to guide comprehensive treatment strategies and determine the eligibility for adjuvant imatinib therapy. To the best of our knowledge, this is the first study to integrate CT morphological and radiomics features into a single predictive model for risk stratification of GISTs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.